🇺🇸 FDA
Pipeline program

Vehicle cream: same formulation of cream as the test product but without active substance and phosphoric acid, Ruxolitinib (INCB018424) cream

INCB018424-316

Phase 3 small_molecule active

Quick answer

Vehicle cream: same formulation of cream as the test product but without active substance and phosphoric acid, Ruxolitinib (INCB018424) cream for Atopic Dermatitis is a Phase 3 program (small_molecule) at Incyte Biosciences Distribution B.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Incyte Biosciences Distribution B.V.
Indication
Atopic Dermatitis
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials